Generic Abilify

TREATMENT OF DEMENTIA: RESEARCH AND THE FUTURE

In the last few years exciting new research has been reported to both the medical and the lay press. Before this time all the research tended to centre on either the drug treatment of dementia or on the social aspects of sufferers. However, it is now generally acknowledged that for the foreseeable future there is not going to be a major breakthrough in the treatment of dementia with drugs, as there was with the use of L-dopa in the treatment of Parkinson's disease. Many drug trials are still being performed, but increasingly the studies either show no change at all or a minor modification of one aspect of the condition, e.g. more placid behaviour or slightly better ability to dress, etc. These minor improvements are very important to the people concerned but will not revolutionize the understanding or ability to treat the condition. The latest drug to arouse considerable interest is Tacrine. Some of the research work does show improvements in certain patients, but at best only moderate improvement in specific areas of testing, e.g. mini-mental state test and some activities of daily living. The researchers felt that in those patients treated there was a small but significant reduction in the rate of decline in cognition. However this was not large enough to influence the global assessment of the patients. True drug therapy is still a long way off.
The social research is moving away from examining the patient and towards understanding the position of the carers and putting their viewpoint across. This is vitally important; for too long this group of people has been taken for granted and their needs ignored. More work is also being done teaching the professionals who come into contact with the elderly and especially the elderly mentally confused. Dramatic changes in policy, finance, resources, etc., will only take place if those in the position to influence such things are aware of the problem. Much research work has shown that, from medical students to politicians, there is a lack of knowledge and interest in the problems of the elderly. This will only change with education and the elderly themselves becoming more of a pressure group to press for reform.

*92/128/5*
GENERAL HEALTH

• The expiry date is mentioned on each blister. It is different for different batches. The shelf life is 2 years from the date of manufacture and would differ from batch to batch depending on when they were manufactured.
• Read the product information leaflet provided with the product before using it.

   

Information that this website contains are general information only and are not intended as a replacement for advise and recommendations made by your medical practitioner. We do not make any warranty or represent the accuracy of information supplied herein. We reserve the right to omit portions, correct errors or withdraw an entire page on this website as we see fit without prior notice. Information about a certain drug, its uses, recommended dosages and side effects do not serve as a substitute to a prescription or information relayed to you by a licensed medical practitioner. These materials are just a general overview about the product. Likewise, we do not endorse use of any drug found on this site. Use of this site is at your sole risk. We disclaim responsibility for reliance you place upon the information that we posted on this site. Always seek medical advice from a professional healthcare and discuss thoroughly your intention of using any of the medicine that is offered in this website.